Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (381-390 of 688) with videos related to

Pageof 69
Sort By:
Circulation. Heart Failure|February 5, 2017
Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Nicolas Girerd, Kevin Duarte, et al.
European Journal of Heart Failure|February 21, 2020
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trialsXavier Rossello, João Pedro Ferreira, Stuart J Pocock, et al.
European Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.
Circulation. Heart Failure|October 18, 2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
JACC. Heart Failure|January 14, 2020
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection FractionMatteo Serenelli, Alice Jackson, Pooja Dewan, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction databaseSonya K Hui, Abhinav Sharma, Kieran Docherty, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
Diabetes, Obesity & Metabolism|September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trialPeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Circulation. Heart Failure|March 4, 2024
Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HFChris J Kapelios, Stephen J Greene, Robert J Mentz, et al.
Pageof 69

Showing results (381-390 of 688) with videos related to

Sort By:
Pageof 69
Circulation. Heart Failure|February 5, 2017
Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Nicolas Girerd, Kevin Duarte, et al.
European Journal of Heart Failure|February 21, 2020
Sex differences in mineralocorticoid receptor antagonist trials: a pooled analysis of three large clinical trialsXavier Rossello, João Pedro Ferreira, Stuart J Pocock, et al.
European Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.
Circulation. Heart Failure|October 18, 2015
Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of SpironolactoneAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Journal of the American College of Cardiology|August 29, 2023
Underutilization of Mineralocorticoid Antagonists in Patients With Heart Failure With Reduced Ejection FractionShingo Matsumoto, Toru Kondo, Pardeep S Jhund, et al.
JACC. Heart Failure|January 14, 2020
Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection FractionMatteo Serenelli, Alice Jackson, Pooja Dewan, et al.
European Heart Journal. Acute Cardiovascular Care|February 23, 2021
Non-fatal cardiovascular events preceding sudden cardiac death in patients with an acute myocardial infarction complicated by heart failure: insights from the high-risk myocardial infarction databaseSonya K Hui, Abhinav Sharma, Kieran Docherty, et al.
Journal of the American College of Cardiology|July 2, 2013
Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)Romain Eschalier, John J V McMurray, Karl Swedberg, et al.
Diabetes, Obesity & Metabolism|September 28, 2021
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trialPeter Rossing, Rajiv Agarwal, Stefan D Anker, et al.
Circulation. Heart Failure|March 4, 2024
Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HFChris J Kapelios, Stephen J Greene, Robert J Mentz, et al.
Pageof 69